.Semaglutide: Novo Nordisk Semaglutide is a long-acting oral GLP-1 analogue being developed and investigated by Novo Nordisk. The drug is currently being evaluated under Phase III clinical trial for ...
In the UK, vascular surgeons performed more than 3,500 amputations in 2023. Peripheral artery disease is the narrowing and blocking of the arteries in the legs. This process of furring up of the ...
Efforts are being made throughout the NHS to reduce the number of amputations performed due to peripheral artery disease. The vascular surgery unit in Glenfield Hospital, Leicester, aimed to ...